期刊文献+

人GDNF-TAT真核表达载体的构建及其在毕赤酵母中的表达

Construction and expression of a eukaryotic vector for human GDNF-TAT in Pichia pastoris
原文传递
导出
摘要 目的:在毕赤酵母中表达带有TAT多肽的人胶质细胞源性神经营养因子(glial cell line-derived neurotro-phic factor,GDNF),为探讨GDNF-TAT用于帕金森病的治疗奠定基础。方法:用密码子优化法合成人GDNF基因序列连在pPICZαA,用PCR方法分别在上游引入TAT位点与XbaⅠ酶切位点,下游设计扩增pPICZαA上的α-因子序列。然后插入pPICZαA载体中,转化大肠杆菌TOP10,筛选阳性克隆,对其进行PCR和双酶切并测序鉴定,构建GDNF-TAT在毕赤酵母表达质粒pPICZαA-GDNF-TAT。电击转化毕赤酵母GS115,对阳性克隆进行诱导表达后经SDS-PAGE和Western印迹鉴定目的蛋白。结果:双酶切pPICZαA-GDNF-TAT后,琼脂糖电泳可分别见到大小约为3.1kb和432bp片段,表明目的片段已插入载体中,经序列测定其含有完整的GDNF-TAT基因片段,Western印迹结果显示含有pPICZαA-GDNF-TAT的毕赤酵母GS115能分泌表达GDNF-TAT。结论:成功构建了毕赤酵母表达载体pPICZαA-GDNF-TAT,并能在毕赤酵母GS115中分泌表达GDNF-TAT。 Objective: To construct and express a Pichia pastoris expression vector of glial cell line-derived nenrotrophic factor(GDNF)-TAT fusion protein in order to explore the application of GDNF-TAT protein to the treatment of Parkinson's disease. Methods:The GDNF gene was synthesized by codon optimization and was ligated to pPICZαA. The GDNF-TAT gene with TAT gene site and Xba I restriction enzyme sites and α-factor of pPICZαA were obtained by PCR and subcloned into the pPICZαA vector. After being identified by restrictive enzymes digestion and sequencing, reconstructed plasmid was transformed into P. pastoris GSll5 by the method of electroporation. Expression of GDNF-TAT protein was assayed in P. pastoris GS115 culture supernatant by SDS and Western blotting. Results :The target gene GDNF-TAT fragment about 432 bp was integrated into the genome of P. pastoris GSll5. The recombinant GDNF-TAT protein with relative molecular mass of 17×10^3 was secreted into the culture supernatant and was confirmed by Western blotting. Conclusion:P. pastoris expression vector pPICZαA-GDNF-TAT was constructed successfully and recombinant GDNF-TAT protein was expressed in P. pastoris GS115.
出处 《军事医学科学院院刊》 CSCD 北大核心 2009年第5期427-430,共4页 Bulletin of the Academy of Military Medical Sciences
关键词 胶质细胞源性神经营养因子 GDNF-TAT基因 电转化 毕赤酵母 血脑屏障 聚合酶链反应 glial cell line-derived neurotrophic factor GDNF-TAT gene electroporation P. pastoris blood brain barrier polymerase chain reaction
  • 相关文献

参考文献10

  • 1Lapchak PA,Gash DM,Collins F,et al.Pharmacological activities of glial cell line-derived neurotrophic factor(GDNF):preclinical development and application to the treatment of Parkinson's disease[J].Exp Neurol,1997,145(2 Pt 1):309-321.
  • 2Weiss R.Promising protein for Parkinson's[J].Science,1993,260(5111):1072-1073.
  • 3Damier P,Hirsch EC,Agid Y,et al.The substantia nigra of the human brain Ⅱ patterns of loss of dopamine-containing neurons in Parkinson's disease[J].Brain,1999,122(Pt8):1437-1448.
  • 4Kilic U,Kilic E,Dietz GPH,et al.Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice[J].Stroke,2003,34(5):1304-1310.
  • 5Nutt JG,Burchiel KJ,Comella CL,et al.Randomized,double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD[J].Neurology,2003,60(1):69-73.
  • 6Slevin JT,Gerhardt GA,Smith CD,et al.Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor[J].J Neurosurg,2005,102(2):216-222.
  • 7Kilic U,Kilic E,Dietz GPH,et al.The TAT protein transduction domain enhances the neuroprotective effect of GDNF after optic nerve transection[J].Neurodegener Dis,2004,1(1):44-49.
  • 8Dietz GP,Valbuena PC,Dietz B,et al.Application of a blood brain-barrier-penetrating form of GDNF in a mouse model for Parkinson's disease[J].Brain Res,2006,1082(1):61-66.
  • 9Daly R,Hearn MT.Expression of heterologous proteins in Pichia pastoris:a useful experimental tool in protein engineering and production[J].J Mol Recognit,2005,18(3):119-138.
  • 10Hui SW.Overview of drug delivery and alternative methods to electroporation[J].Methods Mol Biol,2008,423:91-107.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部